Cite
Prada PO, Ropelle ER, Mourão RH, et al. Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. Diabetes. 2017;66(7):2059doi: 10.2337/db17-rt07a.
Prada, P. O., Ropelle, E. R., Mourão, R. H., de Souza, C. T., Pauli, J. R., Cintra, D. E., Schenka, A., Rocco, S. A., Rittner, R., Franchini, K. G., Vassallo, J., Velloso, L. A., Carvalheira, J. B., & Saad, M. J. A. (2017). Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. Diabetes, 66(7), 2059. https://doi.org/10.2337/db17-rt07a
Prada, Patricia O, et al. "Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185." Diabetes vol. 66,7 (2017): 2059. doi: https://doi.org/10.2337/db17-rt07a
Prada PO, Ropelle ER, Mourão RH, de Souza CT, Pauli JR, Cintra DE, Schenka A, Rocco SA, Rittner R, Franchini KG, Vassallo J, Velloso LA, Carvalheira JB, Saad MJA. Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet-Fed Mice. Diabetes 2009;58:2910-2919. DOI: 10.2337/db08-0506. PMID: 19696185. Diabetes. 2017 Jul;66(7):2059. doi: 10.2337/db17-rt07a. Epub 2017 Apr 27. PMID: 28450418; PMCID: PMC5482084.
Copy
Download .nbib